William Helsel

1.4k total citations
26 papers, 1.1k citations indexed

About

William Helsel is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, William Helsel has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 10 papers in Epidemiology and 4 papers in Molecular Biology. Recurrent topics in William Helsel's work include Global Cancer Incidence and Screening (14 papers), Colorectal Cancer Screening and Detection (12 papers) and Cervical Cancer and HPV Research (9 papers). William Helsel is often cited by papers focused on Global Cancer Incidence and Screening (14 papers), Colorectal Cancer Screening and Detection (12 papers) and Cervical Cancer and HPV Research (9 papers). William Helsel collaborates with scholars based in United States. William Helsel's co-authors include Yoshihiko Tsukamoto, Vicki B. Benard, William Kammerer, Lisa C. Richardson, Arthur Schatzkin, Bernard E. Kreger, Rachel Ballard‐Barbash, William B. Kannel, Keaven M. Anderson and Herschel W. Lawson and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and JNCI Journal of the National Cancer Institute.

In The Last Decade

William Helsel

26 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William Helsel United States	17	640	272	170	149	117	26	1.1k
Gregory Harper United States	20	319 0.5×	164 0.6×	261 1.5×	99 0.7×	76 0.6×	34	1.3k
Margaret Wesley United States	12	450 0.7×	124 0.5×	81 0.5×	58 0.4×	115 1.0×	19	983
Adrienne Morgan United Kingdom	19	282 0.4×	54 0.2×	123 0.7×	247 1.7×	60 0.5×	48	1.2k
Maria Olsen Netherlands	12	318 0.5×	135 0.5×	67 0.4×	132 0.9×	33 0.3×	20	923
Beilei Cai United States	16	351 0.5×	204 0.8×	46 0.3×	143 1.0×	210 1.8×	64	1.5k
Ashley Rosko United States	20	713 1.1×	53 0.2×	151 0.9×	461 3.1×	166 1.4×	122	1.4k
Nathan Brand United States	15	183 0.3×	82 0.3×	146 0.9×	300 2.0×	79 0.7×	44	1.1k
Roya Dolatkhah Iran	15	303 0.5×	87 0.3×	61 0.4×	125 0.8×	56 0.5×	80	864
Hana Fakhoury Saudi Arabia	16	230 0.4×	130 0.5×	116 0.7×	299 2.0×	91 0.8×	71	1.2k
Rachel Peragallo Urrutia United States	17	538 0.8×	191 0.7×	540 3.2×	241 1.6×	127 1.1×	38	1.6k

Countries citing papers authored by William Helsel

Since Specialization

Citations

This map shows the geographic impact of William Helsel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Helsel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Helsel more than expected).

Fields of papers citing papers by William Helsel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Helsel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Helsel. The network helps show where William Helsel may publish in the future.

Co-authorship network of co-authors of William Helsel

This figure shows the co-authorship network connecting the top 25 collaborators of William Helsel. A scholar is included among the top collaborators of William Helsel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Helsel. William Helsel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Scott, Lia C., Michele G. Beckman, Amy DeGroff, et al.. (2022). Geographic Examination of COVID-19 Test Percent Positivity and Proportional Change in Cancer Screening Volume, National Breast and Cervical Cancer Early Detection Program. Preventing Chronic Disease. 19. E59–E59. 6 indexed citations

DeGroff, Amy, Jacqueline W. Miller, Krishna P. Sharma, et al.. (2021). COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January–June 2020, in the United States. Preventive Medicine. 151. 106559–106559. 106 indexed citations

White, Arica, Jacqueline W. Miller, Janet Royalty, et al.. (2015). Clinical outcomes of mammography in the National Breast and Cervical Cancer Early Detection Program, 2009–2012. Cancer Causes & Control. 26(5). 723–732. 8 indexed citations

Benard, Vicki B., et al.. (2015). The effectiveness of targeting never or rarely screened women in a national cervical cancer screening program for underserved women. Cancer Causes & Control. 26(5). 713–719. 21 indexed citations

Seeff, Laura C., Janet Royalty, William Helsel, et al.. (2013). Clinical outcomes from the CDC's Colorectal Cancer Screening Demonstration Program. Cancer. 119(S15). 2820–2833. 27 indexed citations

Benard, Vicki B., et al.. (2012). Timeliness of Cervical Cancer Diagnosis and Initiation of Treatment in the National Breast and Cervical Cancer Early Detection Program. Journal of Women s Health. 21(7). 776–782. 41 indexed citations

Richardson, Lisa C., et al.. (2009). Timeliness of Breast Cancer Diagnosis and Initiation of Treatment in the National Breast and Cervical Cancer Early Detection Program, 1996–2005. American Journal of Public Health. 100(9). 1769–1776. 83 indexed citations

Benard, Vicki B., et al.. (2009). Assessment of Follow-Up for Low-Grade Cytological Abnormalities in the National Breast and Cervical Cancer Early Detection Program, 2000—2005. Obstetrical & Gynecological Survey. 64(2). 103–104. 1 indexed citations

Benard, Vicki B., et al.. (2008). Assessment of Follow-Up for Low-Grade Cytological Abnormalities in the National Breast and Cervical Cancer Early Detection Program, 2000-2005. Journal of Lower Genital Tract Disease. 12(4). 300–306. 8 indexed citations

10.

Will, Julie C., et al.. (2007). A combined approach to women's health is associated with a greater likelihood of repeat mammography in a population of financially disadvantaged women.. PubMed. 4(4). A89–A89. 8 indexed citations

11.

Richardson, Lisa C., et al.. (2007). Timeliness of breast cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP). Journal of Clinical Oncology. 25(18_suppl). 6571–6571. 2 indexed citations

12.

Eheman, Christie R., Vicki B. Benard, Donald Blackman, et al.. (2006). Breast Cancer Screening among Low-Income or Uninsured Women: Results from the National Breast and Cervical Cancer Early Detection Pogram, July 1995 to March 2002 (United States). Cancer Causes & Control. 17(1). 29–38. 37 indexed citations

13.

Benard, Vicki B., et al.. (2005). Adherence to Guidelines for Follow-up of Low-Grade Cytologic Abnormalities Among Medically Underserved Women. Obstetrics and Gynecology. 105(6). 1323–1328. 75 indexed citations

14.

Dorgan, Joanne F., Thomas R. Fears, Rosemary L. Schleicher, et al.. (2004). Serum carotenoids and alpha-tocopherol and risk of nonmelanoma skin cancer.. PubMed. 13(8). 1276–82. 31 indexed citations

15.

Benard, Vicki B., Christie R. Eheman, Herschel W. Lawson, et al.. (2004). Cervical Screening in the National Breast and Cervical Cancer Early Detection Program, 1995–2001. Obstetrics and Gynecology. 103(3). 564–571. 57 indexed citations

16.

Tangrea, Joseph A., et al.. (1994). Risk factors for the development of placebo adverse reactions in a multicenter clinical trial. Annals of Epidemiology. 4(4). 327–331. 10 indexed citations

17.

Tangrea, J A, et al.. (1993). Clinical and laboratory adverse effects associated with long-term, low-dose isotretinoin: incidence and risk factors. The Isotretinoin-Basal Cell Carcinomas Study Group.. PubMed. 2(4). 375–80. 19 indexed citations

18.

Tangrea, J A, et al.. (1993). Patients' perceptions on participation in a cancer chemoprevention trial.. PubMed. 1(3). 325–30. 25 indexed citations

19.

Ballard‐Barbash, Rachel, Arthur Schatzkin, William B. Kannel, et al.. (1990). Body Fat Distribution and Breast Cancer in the Framingham Study. JNCI Journal of the National Cancer Institute. 82(4). 286–290. 140 indexed citations

20.

Wahl, Sharon M., et al.. (1982). Modulation of fibroblast growth by a lymphokine of human T-cell and T-cell-line origin. Cellular Immunology. 70(2). 391–391. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact